Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Avinash Kumar, Sudhanshu Rai, Ekta Rathi, Paridhi Agarwal & Suvarna G. Kini. (2021) Pharmacophore-guided fragment-based design of novel mammalian target of rapamycin inhibitors: extra precision docking, fingerprint-based 2D and atom-based 3D-QSAR modelling. Journal of Biomolecular Structure and Dynamics 39:4, pages 1155-1173.
Read now
Read now
Varadharajan Thiyagarajan, Kuan-Wei Lee, Max K. Leong & Ching-Feng Weng. (2018) Potential natural mTOR inhibitors screened by in silico approach and suppress hepatic stellate cells activation. Journal of Biomolecular Structure and Dynamics 36:16, pages 4220-4234.
Read now
Read now
Articles from other publishers (10)
Connor J. Morris, Jacob A. Stern, Brenden Stark, Max Christopherson & Dennis Della Corte. (2022) MILCDock: Machine Learning Enhanced Consensus Docking for Virtual Screening in Drug Discovery. Journal of Chemical Information and Modeling 62:22, pages 5342-5350.
Crossref
Crossref
K.P. Safna Hussan, Chennattu M. Pareeth, K. Muraleedharan, Mohamed Shahin Thayyil & Thekkekara D. Babu. (2022) Synthesis, spectroscopic, chemical reactivity, molecular docking, DFT calculations and in-vitro anticancer activity studies of a novel ionic liquid; Metforminium ibuprofenate. Journal of Molecular Liquids 364, pages 120046.
Crossref
Crossref
Raef Shams, Yoshihiro Ito & Hideyuki Miyatake. (2022) Mapping of mTOR drug targets: Featured platforms for anti-cancer drug discovery. Pharmacology & Therapeutics 232, pages 108012.
Crossref
Crossref
Andrey V. Markov, Kirill V. Odarenko, Anna A. Ilyina & Marina A. Zenkova. (2022) Uncovering the anti-angiogenic effect of semisynthetic triterpenoid CDDO-Im on HUVECs by an integrated network pharmacology approach. Computers in Biology and Medicine 141, pages 105034.
Crossref
Crossref
Srilatha Sakamuru, Jinghua Zhao, Menghang Xia, Huixiao Hong, Anton Simeonov, Iosif Vaisman & Ruili Huang. (2021) Predictive Models to Identify Small Molecule Activators and Inhibitors of Opioid Receptors. Journal of Chemical Information and Modeling 61:6, pages 2675-2685.
Crossref
Crossref
Shahrukh Qureshi, Ravina Khandelwal, Maddala Madhavi, Naveesha Khurana, Neha Gupta, Saurav K. Choudhary, Revathy A. Suresh, Lima Hazarika, Chillamcherla D. Srija, Khushboo Sharma, Mali R. Hindala, Tajamul Hussain, Anuraj Nayarisseri & Sanjeev K. Singh. (2021) A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma. Current Topics in Medicinal Chemistry 21:9, pages 790-818.
Crossref
Crossref
Oscar Herrera-Calderon, Andres F. Yepes-Pérez, Jorge Quintero-Saumeth, Juan Pedro Rojas-Armas, Miriam Palomino-Pacheco, José Manuel Ortiz-Sánchez, Edwin César Cieza-Macedo, Jorge Luis Arroyo-Acevedo, Linder Figueroa-Salvador, Gilmar Peña-Rojas & Vidalina Andía-Ayme. (2020) Carvacrol: An In Silico Approach of a Candidate Drug on HER2, PI3Kα, mTOR, hER-α, PR, and EGFR Receptors in the Breast Cancer. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-12.
Crossref
Crossref
Ninie Nadia Zulkipli, Rahimah Zakaria, Idris Long, Siti Fadilah Abdullah, Erma Fatiha Muhammad, Habibah A. Wahab & Teguh Haryo Sasongko. (2020) In Silico Analyses and Cytotoxicity Study of Asiaticoside and Asiatic Acid from Malaysian Plant as Potential mTOR Inhibitors. Molecules 25:17, pages 3991.
Crossref
Crossref
Aimen K. Aljoundi, Clement Agoni, Fisayo A. Olotu & Mahmoud E.S. Soliman. (2019) Turning to Computer-aided Drug Design in the Treatment of Diffuse Large B-cell Lymphoma: Has it been Helpful?. Anti-Cancer Agents in Medicinal Chemistry 19:11, pages 1325-1339.
Crossref
Crossref
Mohd Rehan. (2017) An Anti‐Cancer Drug Candidate OSI‐027 and its Analog as Inhibitors of mTOR: Computational Insights Into the Inhibitory Mechanisms. Journal of Cellular Biochemistry 118:12, pages 4558-4567.
Crossref
Crossref